for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

CureVac says no requests to reserve production for U.S., scientists were not lured

FRANKFURT (Reuters) - German vaccine developer CureVac has not received a takeover offer from the United States, was not asked to reserve production slots nor were its scientists lured to move to the U.S., the firm’s acting Chief Executive Franz-Werner Haas said in a media call on Tuesday.

Reporting by Ludwig Burger; Editing by Michelle Martin

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up